Sort
78,016 grants matching “breast cancer”
COULD HER2 HETEROGENEITY OPEN NEW THERAPEUTIC OPTIONS IN PATIENTS WITH HER2- PRIMARY BREAST CANCER?
$538,563Sloan-Kettering Institute For Cancer Research · · FY2014 · Department of the Army
Upgrading rigor and efficiency of germline cancer gene variant classification for the 2020s
$538,540Sean Vahram Tavtigian · University Of Utah · R01 · FY2023 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$538,522William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials
$538,509Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
HIERARCHICAL MODELING OF INTERACTIONS IN GENOME-WIDE AND PATHWAY-BASED STUDIES
$538,428David V Conti · University Of Southern California · R01 · FY2009 · ES
Targeted chemotherapy delivery and capture
$538,425Rahmi Oklu · Mayo Clinic Arizona · R01 · FY2020 · EB
Mechanistic Studies of Genetic Recombination
$538,384Stephen Charles Kowalczykowski · University Of California At Davis · R01 · FY2010 · GM
Delineating the dystopian nature of the cell cycle in cancer
$538,372Erik Knudsen · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
An Electronic Health Record-Based Tool to Identify Newly Diagnosed Breast Cancer Patients at Risk of Low Social Support
$538,338Candyce H Kroenke · Kaiser Foundation Research Institute · R01 · FY2022 · CA
Navigation from Community to Clinic to promote CRC Screening in Underserved Popul
$538,307Linda K Larkey · Arizona State University-Tempe Campus · R01 · FY2016 · CA
Adolescents' Long-Term Adaptation to Familial Cancer Risks
$538,281Kenneth Tercyak · Georgetown University · R01 · FY2013 · CA
Project 3: From Networks and Structures to Hierarchical Whole Cell Models of Cancer
$538,261Trey Ideker · University Of California, San Francisco · U54 · FY2022 · CA
Targeting tumor-associated macrophages for triple-negative breast cancer treatment
$538,218Mingye Feng · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization
$538,137David A Mankoff · University Of Pennsylvania · R01 · FY2024 · CA
Promoting tumor cell apoptosis by death ligands
$538,134Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Occupational Exposure Assessment
$538,124Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
DEVELOPMENTAL FUNDS (Core 002)
$538,114Robert L Ferris · University Of Pittsburgh At Pittsburgh · P30 · FY2019 · CA
DEVELOPMENTAL FUNDS (Core 002)
$538,114Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · CA
Integrated genomic approaches to identify and validate cancer targets
$538,078William C Hahn · Dana-Farber Cancer Inst · R33 · FY2010 · CA
SES Disparities in Breast Cancer: Effect of Pharmaceutical Coverage
$538,061Ann B. Nattinger · Medical College Of Wisconsin · R01 · FY2010 · CA
Targeted chemotherapy delivery and capture
$538,020Rahmi Oklu · Mayo Clinic Arizona · R01 · FY2018 · EB
New Vulnerabilities in MYC-Driven Breast Cancer
$538,015Thomas Westbrook · Baylor College Of Medicine · R01 · FY2022 · CA
Mechanisms of Genome Integrity
$537,987Eric C Greene · Columbia University Health Sciences · R35 · FY2017 · GM
MICRO-INSTRUMENT PLATFORMS FOR GENETIC-BASED ANALYSES
$537,986Louisiana State Univ A&M Col Baton Rouge · R24 · FY2002 · CA
Facilitating Adjustment in Low-Income Black Women with Breast Cancer
$537,975Suzanne C Lechner · University Of Miami School Of Medicine · R01 · FY2012 · CA